Treatment for gastric lesions
AssigneeBurroughs Wellcome Co.
InventorSalvador E. Moncada
Life of this patent
Estimating the term…
Abstract
Pharmaceutical combinations comprising (a) prostacyclin, dihydroprostacyclin or a pharmaceutically acceptable salt of either of these, and (b) a phosphodiesterase inhibitor. Pharmaceutical formulations comprising a combination as above and a pharmaceutically acceptable carrier. Methods are disclosed for preparing the combinations and the formulations. The combinations and formulations are useful for preventing or minimising platelet aggregation in blood, blood products or blood substitutes for example in the treatment of thrombosis, gastric lesions and wounds, and in the extra-corporeal circulation of blood and in blood separation processes.
Claims4
A method for prophylaxis and/or treatment of a gastric lesion in a mammal, which comprises simultaneously or sequentially internally administering 1 part by weight of (a) a compound selected from the group consisting of prostacyclin, dihydroprostacyclin, and their pharmaceutically acceptable salts, in an amount insufficient to cause vasodilation, and 1 to 200 parts by weight of (b) a phosphodiesterase inhibitor selected from the group consisting of theophylline, 3-isobutyl-1-methyl xanthine, dipyridamole, a pharmaceutically acceptable salt of theophylline, a pharmaceutically acceptable salt of dipyridamole, and a pharmaceutically acceptable salt of 3-isobutyl-1-methyl xanthine.
A method for the treatment of a gastric lesion in a mammal which comprises the internal administration of an effective gastric lesion treatment amount of 1 part by weight of sodium prostacyclin and 1 to 200 parts by weight of a phosphodiesterase inhibitor selected from the group consisting of theophylline, 3-isobutyl-1-methyl xanthine, dipyridamole, a pharmaceutically acceptable salt of theophylline, a pharmaceutically acceptable salt of dipyridamole, and a pharmaceutically acceptable salt of 3-isobutyl-1-methyl xanthine.
Dependencies are inferred from the claim text.